Knowledge Center

Patent / 2019

Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease

Hovione Patent

Authors:
  • Nuno Lourenço
  • Luis Sobral
  • Joana Fernandes
Source:
WO 2019016512 20190124

The present invention relates to an amorphous form of vilanterol trifenatate, processes for its prepn. and its use in pharmaceutical formulations for the treatment of respiratory diseases, particularly for the treatment of asthma and chronic obstructive pulmonary disease. In particular, the invention relates to an amorphous form of vilanterol trifenatate, characterized by the x-ray powder diffraction (XRPD) pattern, obtained using copper K-α1 radiation.

Also in the Knowledge Center

Related content

Jet milling

Jet milling is widely used in the pharmaceutical industry and remains the leading technology for particle size reduction and is most commonly used for having consistent and uniform particles during formulation.

Page
Read more

Hovione’s contributions to the Sustainable Development Goals

Hovione has aligned its Sustainability Policy and Strategy to the United Nations Sustainable Development Goals

Page
Read more

Inhalation devices

Hovione’s inhalers offer our business partners access to simple, multipurpose, easy to use, globally competitive alternatives for inhalation delivery devices.

Page
Read more